Effect of secukinumab on quality of life and psoriasis‐related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52‐week study
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2017.10.025
Abstract: Background: Secukinumab has demonstrated greater sustained skin clearance than ustekinumab through week 52, greater improvement in symptoms and health‐related quality of life, and comparable safety profile. Objective: To assess the impact of secukinumab versus that… read more here.
Keywords: versus ustekinumab; psoriasis related; psoriasis; quality life ... See more keywords
Rethinking costs of psoriasis: 10% of patients account for nearly 40% of healthcare expenditures among enrollees with psoriasis in a U.S. health plan
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2017.1303566
Abstract: Abstract Objective: To examine characteristics, healthcare utilization and costs among patients with psoriasis who have high medical costs. Methods: This is a retrospective study of patients with psoriasis with continuous enrollment from 1 January 2011… read more here.
Keywords: psoriasis; healthcare expenditures; psoriasis related; health plan ... See more keywords
Pain associated with psoriasis: a qualitative study.
Sign Up to like & getrecommendations! Published in 2023 at "Pain medicine"
DOI: 10.1093/pm/pnad067
Abstract: BACKGROUND Pain is a major factor in the psychosocial impact of psoriasis. There is a paucity of qualitative reports of dermatologists' views on psoriasis-related pain. OBJECTIVES The aim of this study was to explore the… read more here.
Keywords: pain associated; psoriasis related; pain; psoriasis ... See more keywords